lucA Resolved · high auto-curated

H37Rv Rv3723 · MTBC0 mtbc0_003948 · 254 aa · 4192657–4193421 MTBC0 (+) · RefSeq NP_218240.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)transmembrane protein
MTBC0 PGAP re-annotationlipid uptake coordinator LucA
Revised (this work)Lipid uptake coordinator LucA. Pfam: LUCA (PF26307.1).
Functional category (TubercuList)cell wall and cell processes

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 7 publications

7 TB publications mention this gene. 7 publications discuss this gene (count verified against title and abstract text). Queried separately, 8 records carry a M. tuberculosis context and none a non-TB mycobacterial context. The three counts come from three distinct PubMed queries (the total is text-verified, the context counts are raw query volumes), so they neither partition the total nor need to add up to it.

5 of 7: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Differential expression of genes associated with lipid import, β-oxidation and lactate oxidation induced by Mycobacterium tuberculosis curli pili in broth culture compared to intracellular bacilli within THP-1 macrophages. doi:10.1099/jmm.0.001994 2025
MceG stabilizes the Mce1 and Mce4 transporters in Mycobacterium tuberculosis. doi:10.1016/j.jbc.2023.102910 2023
Evaluation of Thio- and Seleno-Acetamides Bearing Benzenesulfonamide as Inhibitor of Carbonic Anhydrases from Different Pathogenic Bacteria. doi:10.3390/ijms21020598 2020
Proteomic changes in Mycobacterium tuberculosis H37Rv under hyperglycemic conditions favour its growth through altered expression of Tgs3(Rv3234c) and supportive proteins (Rv0547c, AcrA1 and Mpa). doi:10.1016/j.tube.2019.03.006 2019
The genetic requirements of fatty acid import by Mycobacterium tuberculosis within macrophages. doi:10.7554/eLife.43621 2019
156 records returned by the alias sweep

Searched as: Rv3723, lucA, Mb3750, ML2337, MMAR_5242, MSMEG_6288, MAB_0283c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

This count disagrees with the 7 reported above. The two come from different methods and both are shown rather than one being silently overwritten. The figure above comes from the older curated source, which missed this gene; the sweep below queries every alias of the gene in a mycobacterial context. Where they differ this way, the list below is the one you can check line by line.

PublicationJournalYear
Characterization of novel mycobacteriophages with a focus on phage Pisa4 and its interaction with human innate immune cells. doi:10.3389/fmicb.2026.1823245 Front Microbiol 2026
Mce transport systems in Mycobacterium tuberculosis: architecture, regulation, lipid import, and translational perspectives. doi:10.1128/jb.00221-26 J Bacteriol 2026
Sertoli cells as potential agents against mycobacterial infections. doi:10.1186/s12866-026-05097-2 BMC Microbiol 2026
Animal Tissue Mineralization: An Overview of Disease Processes, Comparative Pathology, and Diagnostic Approaches. doi:10.3390/biom16010096 Biomolecules 2026
Tuberculous Constrictive Pericarditis in Immunocompetent Migrants From High-Incidence Countries: A Conservative Approach in a Low-Incidence Setting. doi:10.1016/j.jaccas.2025.106413 JACC Case Rep 2026
CT Imaging Features of Pulmonary Sarcoidosis: Typical and Atypical Radiological Features and Their Differential Diagnosis. doi:10.3390/medicina61122094 Medicina (Kaunas) 2025
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. doi:10.1016/S0140-6736(25)01637-X Lancet 2025
Splenomegaly in CVID patients associates with CMV replication and alterations of immune cells and functions. doi:10.1016/j.imlet.2025.107058 Immunol Lett 2025
A long-term real-world safety study of guselkumab in patients with psoriasis who have infectious comorbidities, malignancies or heart disease: the EARLY study. doi:10.1093/ced/llaf172 Clin Exp Dermatol 2025
Differential expression of genes associated with lipid import, β-oxidation and lactate oxidation induced by Mycobacterium tuberculosis curli pili in broth culture compared to intracellular bacilli within THP-1 macrophages. doi:10.1099/jmm.0.001994 J Med Microbiol 2025
Chasing the "White Plague" in the Barbaricum of the Carpathian Basin - A case with tuberculous meningitis discovered in a Sarmatian-period (2nd-3rd-century-CE) storage pit from the archaeological site of Kiskundorozsma-Daruhalom-dűlő II (Hungary). doi:10.1016/j.tube.2025.102632 Tuberculosis (Edinb) 2025
Nocturnal short-term heart rate variability reflects impaired daytime vigilance better than overnight heart rate variability in suspected obstructive sleep apnea patients. doi:10.1093/sleep/zsae282 Sleep 2025
Global, regional, and national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019. doi:10.1016/j.puhe.2024.06.011 Public Health 2024
Mycobacteriophages and Their Applications. doi:10.3390/antibiotics13100926 Antibiotics (Basel) 2024
A glimpse into the past of Hansen's disease - Re-evaluation and comparative analysis of cases with leprosy from the Avar period of the Trans-Tisza region, Hungary. doi:10.1016/j.tube.2024.102552 Tuberculosis (Edinb) 2024
Tuberculosis in a Migrant Population: Integrated Management of a Case through the Prevention Department and Hospital Services. doi:10.3390/microorganisms12061216 Microorganisms 2024
Discovery of 2-phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate. doi:10.1002/ardp.202400296 Arch Pharm (Weinheim) 2024
Management of Psoriasis Patients with Serious Infectious Diseases. doi:10.1007/s12325-024-02873-2 Adv Ther 2024
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. doi:10.1016/S0140-6736(24)00367-2 Lancet 2024
Recent advances in lung cancer research: unravelling the future of treatment. doi:10.1007/s13304-024-01841-3 Updates Surg 2024
Antibiotic Therapy for Active Crohn's Disease Targeting Pathogens: An Overview and Update. doi:10.3390/antibiotics13020151 Antibiotics (Basel) 2024
The first probable case with tuberculous meningitis from the Hun period of the Carpathian Basin - How diagnostics development can contribute to increase knowledge and understanding of the spatio-temporal distribution of tuberculosis in the past. doi:10.1016/j.tube.2023.102372 Tuberculosis (Edinb) 2023
Communication to promote and support physical distancing for COVID-19 prevention and control: a rapid review. doi:10.1002/14651858.CD015144 Cochrane Database Syst Rev 2023
Leprosy: The age-old companion of humans - Re-evaluation and comparative analysis of Avar-period cases with Hansen's disease from the Danube-Tisza Interfluve, Hungary. doi:10.1016/j.tube.2023.102393 Tuberculosis (Edinb) 2023
Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea-COPD overlap syndrome: data from the European Sleep Apnoea Database. doi:10.1183/23120541.00676-2022 ERJ Open Res 2023
Pediatric COVID-TB: A Clinical Perspective Based on the Analysis of Three Cases. doi:10.3390/children10050863 Children (Basel) 2023
Profile of Newly Diagnosed Patients with HIV Infection in North-Eastern Romania. doi:10.3390/medicina59030440 Medicina (Kaunas) 2023
Sleep-Disordered Breathing and Chronic Respiratory Infections: A Narrative Review in Adult and Pediatric Population. doi:10.3390/ijms24065504 Int J Mol Sci 2023
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis. doi:10.1111/all.15679 Allergy 2023
MceG stabilizes the Mce1 and Mce4 transporters in Mycobacterium tuberculosis. doi:10.1016/j.jbc.2023.102910 J Biol Chem 2023
Arterial bicarbonate is associated with hypoxic burden and uncontrolled hypertension in obstructive sleep apnea - The ESADA cohort. doi:10.1016/j.sleep.2022.11.041 Sleep Med 2023
Lumbosacral tuberculosis, a rare manifestation of Pott's disease - How identified human skeletons from the pre-antibiotic era can be used as reference cases to establish a palaeopathological diagnosis of tuberculosis. doi:10.1016/j.tube.2022.102287 Tuberculosis (Edinb) 2023
Baseline clusters and the response to positive airway pressure treatment in obstructive sleep apnoea patients: longitudinal data from the European Sleep Apnea Database cohort. doi:10.1183/23120541.00132-2022 ERJ Open Res 2022
Could different aqueous humor and plasma cytokine profiles help differentiate between ocular sarcoidosis and ocular tuberculosis? doi:10.1007/s00011-022-01601-2 Inflamm Res 2022
Management of obstructive sleep apnea in Europe - A 10-year follow-up. doi:10.1016/j.sleep.2022.06.001 Sleep Med 2022
Unveiling the Phytochemical Profile and Biological Potential of Five Artemisia Species. doi:10.3390/antiox11051017 Antioxidants (Basel) 2022
Please stop the Russian-Ukrainian war - children will be more than grateful. doi:10.1007/s00431-022-04444-5 Eur J Pediatr 2022
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. doi:10.1016/S0140-6736(21)02724-0 Lancet 2022
The Immune System Throws Its Traps: Cells and Their Extracellular Traps in Disease and Protection. doi:10.3390/cells10081891 Cells 2021
Critically Ill Coronavirus Disease 2019 Patients Exhibit Hyperactive Cytokine Responses Associated With Effector Exhausted Senescent T Cells in Acute Infection. doi:10.1093/infdis/jiab425 J Infect Dis 2021
Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial. doi:10.1016/j.ctarc.2021.100427 names it Cancer Treat Res Commun 2021
Intraocular Tuberculosis: A Challenging Case Mimicking Wet Age-Related Macular Degeneration. doi:10.1159/000512578 Case Rep Ophthalmol 2021
Tuberculosis in schools: an outbreak in northeastern Italy and some key health protection interventions. doi:10.3325/cmj.2021.62.90 Croat Med J 2021
Obstructive sleep apnoea in adult patients post-tonsillectomy. doi:10.1016/j.sleep.2020.11.024 Sleep Med 2021
Superior hypertension control with betablockade in the European Sleep Apnea Database. doi:10.1097/HJH.0000000000002629 J Hypertens 2021
Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. doi:10.1007/s00134-019-05878-6 Intensive Care Med 2020
TbD1 deletion as a driver of the evolutionary success of modern epidemic Mycobacterium tuberculosis lineages. doi:10.1038/s41467-020-14508-5 Nat Commun 2020
Evaluation of Thio- and Seleno-Acetamides Bearing Benzenesulfonamide as Inhibitor of Carbonic Anhydrases from Different Pathogenic Bacteria. doi:10.3390/ijms21020598 Int J Mol Sci 2020
Periodic limb movements during sleep and blood pressure changes in sleep apnoea: Data from the European Sleep Apnoea Database. doi:10.1111/resp.13760 Respirology 2020
Phenolic compounds of Iris adriatica and their antimycobacterial effects. doi:10.2478/acph-2019-0037 Acta Pharm 2019
The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant. doi:10.3390/pharmaceutics11100508 Pharmaceutics 2019
Spectroscopic Characterization of Bovine, Avian and Johnin Purified Protein Derivative (PPD) with High-Throughput Fourier Transform InfraRed-Based Method. doi:10.3390/pathogens8030136 Pathogens 2019
Proteomic changes in Mycobacterium tuberculosis H37Rv under hyperglycemic conditions favour its growth through altered expression of Tgs3(Rv3234c) and supportive proteins (Rv0547c, AcrA1 and Mpa). doi:10.1016/j.tube.2019.03.006 Tuberculosis (Edinb) 2019
The genetic requirements of fatty acid import by Mycobacterium tuberculosis within macrophages. doi:10.7554/eLife.43621 Elife 2019
An international perspective on hospitalized patients with viral community-acquired pneumonia. doi:10.1016/j.ejim.2018.10.020 Eur J Intern Med 2019
Non-specific Effects of Vaccines Illustrated Through the BCG Example: From Observations to Demonstrations. doi:10.3389/fimmu.2018.02869 Front Immunol 2018
New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies. doi:10.3390/molecules23071506 Molecules 2018
Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases. doi:10.1007/s10792-016-0434-x Int Ophthalmol 2018
Rv3723/LucA coordinates fatty acid and cholesterol uptake in Mycobacterium tuberculosis. doi:10.7554/eLife.26969 names it Elife 2017
Long-lasting tuberculous pleurisy. doi:10.1183/13993003.02472-2016 Eur Respir J 2017
Proteomic analysis of protein purified derivative of Mycobacterium bovis. doi:10.1186/s12967-017-1172-1 J Transl Med 2017
Screening for Tuberculosis in Health Care Workers: Experience in an Italian Teaching Hospital. doi:10.1155/2017/7538037 Biomed Res Int 2017
Proceedings of The 8th Romanian National HIV/AIDS Congress and The 3rd Central European HIV Forum : Sibiu, Romania. 5-7 May 2016. doi:10.1186/s12879-016-1480-8 BMC Infect Dis 2016
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question. doi:10.1007/s40620-015-0243-8 J Nephrol 2016
Bacterial infection remodels the DNA methylation landscape of human dendritic cells. doi:10.1101/gr.192005.115 Genome Res 2015
Adverse reactions of biological therapy for psoriasis. Rev Med Chir Soc Med Nat Iasi 2015
Hamsi scoring in the prediction of unfavorable outcomes from tuberculous meningitis: results of Haydarpasa-II study. doi:10.1007/s00415-015-7651-5 J Neurol 2015
In vitro T-cell profile induced by BCG Moreau in healthy Brazilian volunteers. doi:10.4161/21645515.2014.970954 Hum Vaccin Immunother 2015
Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry. doi:10.1111/bjd.13539 Br J Dermatol 2015
The microbiological diagnosis of tuberculous meningitis: results of Haydarpasa-1 study. doi:10.1111/1469-0691.12478 Clin Microbiol Infect 2014
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis. doi:10.1007/s15010-014-0599-z Infection 2014
Predictors of adverse outcomes in HIV-1-infected children receiving combination antiretroviral treatment: results from a DREAM cohort in sub-Saharan Africa. doi:10.1097/INF.0b013e3182a0994b Pediatr Infect Dis J 2014
History of BCG Vaccine. Maedica (Bucur) 2013
Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2. doi:10.1111/sji.12052 Scand J Immunol 2013
TB meningitis in HIV-positive patients in Europe and Argentina: clinical outcome and factors associated with mortality. doi:10.1155/2013/373601 Biomed Res Int 2013
Risk of tuberculosis following HIV seroconversion in high-income countries. doi:10.1136/thoraxjnl-2012-201740 Thorax 2013
The ESX-5 associated eccB-EccC locus is essential for Mycobacterium tuberculosis viability. doi:10.1371/journal.pone.0052059 PLoS One 2012
Tuberculosis meningo-encephalitis with positive csf for KB and slowly favourable evolution. Case report. Rev Med Chir Soc Med Nat Iasi 2012
Tuberculous meningitis--clinical and epidemiological considerations (a retrospective study 2008-2011). Rev Med Chir Soc Med Nat Iasi 2012
Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 type VII secretion: encoded PE-PPE proteins predicts vaccine potential. doi:10.1016/j.chom.2012.03.003 Cell Host Microbe 2012
Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. doi:10.1111/j.1365-2958.2012.08001.x Mol Microbiol 2012
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition. doi:10.1093/cid/cir900 Clin Infect Dis 2012
Dorsal prevertebral lesions in Wegener granulomatosis: report on four cases. doi:10.1016/j.jbspin.2010.07.017 Joint Bone Spine 2011
[The utility of QuantiFERON TB Gold for diagnosing tuberculous meningitis in children]. Rev Med Chir Soc Med Nat Iasi 2010
[Clinical aspects of tuberculous meningitis in children]. Rev Med Chir Soc Med Nat Iasi 2010
[Role of in vitro tests in the diagnosis of latent tubercular infections]. G Ital Med Lav Ergon 2010
Synthesis and antituberculosis activity of some new pyridazine derivatives. Part II. doi:10.1016/j.ejmech.2010.08.029 Eur J Med Chem 2010
Recurrent cutaneous abscesses in two Italian family members. doi:10.4081/idr.2010.e11 Infect Dis Rep 2010
The BCG1619c gene is not essential for invasion and intracellular persistence of Mycobacterium bovis BCG in human THP-1 and A549 cell lines. doi:10.1139/w09-053 Can J Microbiol 2009
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. doi:10.1097/QAD.0b013e3283326879 AIDS 2009
Performance of tests for latent tuberculosis in different groups of immunocompromised patients. doi:10.1378/chest.08-2575 Chest 2009
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. doi:10.1086/597468 Clin Infect Dis 2009
Your diagnosis? A 12-year-old girl with latent tuberculosis presenting with nausea, vomiting and increasing frontal headache. doi:10.1007/s00431-008-0814-y Eur J Pediatr 2009
[Gamma interferon testing in blood and cerebrospinal fluid--rapid method for the diagnosis of tuberculous meningitis]. Rev Med Chir Soc Med Nat Iasi 2008
[Cryptococcus meningitis, five years of experience and literature review]. Rev Med Chir Soc Med Nat Iasi 2008
Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. doi:10.1093/aje/kwn179 Am J Epidemiol 2008
Differential fadE28 expression associated with phenotypic virulence of Mycobacterium tuberculosis. doi:10.1016/j.micpath.2008.01.006 Microb Pathog 2008
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay. doi:10.1586/17476348.2.2.253 Expert Rev Respir Med 2008
An update on the diagnosis of tuberculosis infection. doi:10.1164/rccm.200509-1516PP Am J Respir Crit Care Med 2006
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. Monaldi Arch Chest Dis 2002
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy. doi:10.1097/00126334-200204150-00018 J Acquir Immune Defic Syndr 2002
Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. doi:10.1097/00126334-200104010-00006 J Acquir Immune Defic Syndr 2001
Application of molecular methods for detection and transmission analysis of mycobacterium tuberculosis drug resistance in patients attending a reference hospital in Italy. doi:10.1086/314677 J Infect Dis 1999
BCG and prospects for new vaccines against tuberculosis. Rays 1998
Epidemiology of multidrug-resistant tuberculosis. Rays 1998
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media. doi:10.1128/JCM.36.6.1530-1533.1998 J Clin Microbiol 1998
[The streptococcal and staphylococcal toxic shock syndrome. Comments on 4 cases]. Rev Med Chir Soc Med Nat Iasi 1995
[An update on the therapy of tuberculous meningitis]. Rev Med Chir Soc Med Nat Iasi 1995
[Pulmonary tuberculosis in an immigrant population: the epidemiological aspects and clinical picture]. Arch Monaldi Mal Torace 1990
[Clinical and laboratory aspects of 105 cases of tuberculous meningitis]. Rev Med Chir Soc Med Nat Iasi 1983
[Latent female genital tuberculosis and sterility]. Arch Ostet Ginecol 1982
[Inhibition of the biosynthesis of thyroglobulin in the thyroid gland of rats by isoniazid]. C R Seances Soc Biol Fil 1982
[A state of "epileptoid pathological impulsiveness" secondary to occasional dyspyridoxinosis caused by prolonged administration of isoniazid]. Minerva Pediatr 1975
[Findings concerning the current distribution of tubercular infection in the Province of Cosenza]. Arch Monaldi 1972
[Experimental studies of the pathogenic action of some nonphotochromogenic atypical mycobacteria]. Ftiziologia 1971
[Problems of aspecific pathogenesis in tubercular manifestations of adolescence]. Minerva Pediatr 1970
[Experimental evolution of mycobacteria to "L" forms in vivo]. Arch Roum Pathol Exp Microbiol 1970
[Studies of the antibiotic action of a strain of Staphylococcus on Mycobacteria]. Rev Med Chir Soc Med Nat Iasi 1970
Neurotoxic effects of cycloserine therapy in pulmonary tuberculosis of adolescents and young adults. Scand J Respir Dis Suppl 1970
[Tuberculosis in the first 20 years of life in the Province of Caserta. Epidemiological, clinical and social observations for the period 1963-66]. Rass Int Clin Ter 1968
[On the radical treatment of morbid tubercular manifestations of the lung]. Minerva Pediatr 1966
[Present state of diffusion of tubercular infection in the school population in Caserta province]. Rass Int Clin Ter 1965
[Some present aspects of chronic tubercular morbidity in the area of work]. Lotta Tuberc 1965
[ASPECTS OF BOVINE TUBERCULOSIS IN THE REGION OF IASI]. Rev Med Chir Soc Med Nat Iasi 1964
[Some medico-social aspects of the tuberculosis morbidity occurring in Campania during the year 1961]. Rass Int Clin Ter 1963
[The function of the antituberculosis dispensary understood as a center for the detection and diagnosis of social diseases]. Rass Int Clin Ter 1963
[Hepatic tuberculosis in childhood (apropos of 2 cases)]. Minerva Pediatr 1962
[On several "new" aspects of tuberculosis modified by bacteriostatics. I. Histomorphological study]. Lotta Tuberc 1961
[Problems of pathogenesis and therapy of amenorrhea in genital tuberculosis]. Zentralbl Gynakol 1959
[Closure of tuberculous pulmonary caverns with antibiotics]. Lotta Tuberc 1957
[Stability in culture of the quantitative rates of mixed populations of streptomycin-sensitive and streptomycin-resistant tuberculosis bacilli]. Arch Tisiol Mal Appar Respir 1955
[Clinico-statistical data on 254 families in which tuberculosis was ascertained at the Centro Diagnostico dell'Istituto Principi di Piemonte]. Arch Tisiol Mal Appar Respir 1955
[A case of bronchial lymph node perforation in an adult]. Arch Tisiol Mal Appar Respir 1953
[Pulmonary tuberculosis in subjects more than 50 years old as seen in the material of the Princes of Piedmont Health Institute]. Arch Tisiol Mal Appar Respir 1953
[Adrenocortical function in tuberculosis in infants treated with isoniazid]. Acta Paediatr Lat 1953
[Adenopathies in the course of pulmonary tuberculosis]. Rass Int Clin Ter 1953
[Effect of isonicotinic acid hydrazide on pulmonary tuberculous caverns]. Arch Tisiol Mal Appar Respir 1953
[Acute primary pulmonary tuberculous processes in aged]. Arch Tisiol Mal Appar Respir 1953
[Case of pulmonary cancer in a 21/2 year old child]. Gruzlica (1926) 1952
The association of miliary tuberculosis of the bone marrow and pancytopenia. doi:10.7326/0003-4819-37-5-1044 Ann Intern Med 1952
[Considerations on recurrence of tuberculosis following streptomycin therapy]. Arch Tisiol Mal Appar Respir 1952
[Therapy of tuberculous empyema]. G Med Mil 1952
[Cutaneous tuberculosis; therapy]. Rass Int Clin Ter 1952
[Immunobiological changes in body fluids in B.C.G. vaccination; effect of age and vaccine dosage]. Lattante 1952
[Levinson's reaction in tuberculous meningitis]. Acta Paediatr Lat 1952
[Para-succinylaminobenzaldehyde thiosemicarbazone in the treatment of tuberculous empyema]. Gazz Med Ital 1952
[Alcoholic infiltration of the phrenic nerve and pneumoperitoneum in the treatment of pleurisy complicated by pneumothorax]. Minerva Med 1951
[Cutaneous tuberculosis; symptomatology, course, prognosis and differential diagnosis]. Rass Int Clin Ter 1951
[Variations of cholesterolemia in children with tuberculosis treated with streptomycin]. Boll Soc Ital Biol Sper 1951
[Skin tuberculosis. I. Etiology, pathogenesis, histology, classification]. Rass Int Clin Ter 1951
[Giant caverns treated with endocavitary drainage]. Arch Tisiol Mal Appar Respir 1951
[Statistical findings and elements of prognostic evaluation of 32 patients with tuberculous meningitis treated with streptomycin]. Arch Tisiol Mal Appar Respir 1950
Bronchitis plastic in pulmonary tuberculosis. Antiseptic 1950
[Association of therapeutic pneumothorax and streptomycin]. Arch Tisiol Mal Appar Respir 1950
[On the surgical treatment of the large tuberculous caves of the upper lung lobe]. Archivio Chir Torace 1948
[Some data on the course of pulmonary tuberculosis in the war period]. Arch Tisiol Mal Appar Respir 1947

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Intrinsic disorder (sequence + structure) highly disordered

Predicted disorder45% of residues (metapredict) · mean AlphaFold pLDDT 71.1
Disordered regions1 IDR(s), longest 114 aa [140-254]

sequence-based disorder is high but AlphaFold folds it confidently (pLDDT>=70): treat the disorder call with caution (possible metapredict over-call)

A property (biophysics), not a function. No LLPS/condensate claim is made from disorder alone. Verdict unchanged. Source: metapredict v3 (Emenecker/Holehouse) per-residue disorder + AlphaFold mean pLDDT (annotation_mtbc P16.13).

CRISPRi vulnerability

Vulnerability index -0.01 (95% CI -1.49 to 1.99). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.377 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=7 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3750 · 100.0% identity
M. leprae ML2337 · 53.0% identity
M. marinum MMAR_5242 · 87.6% identity
M. smegmatis MSMEG_6288 · 70.2% identity
M. orygis RJtmp_003829 · 100.0% identity
M. abscessus MAB_0283c · 56.5% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt O69690 SwissProt · reviewed · Evidence at protein level
UniProt nameLipid uptake coordinator A
Curated functionRequired for the import of both fatty acids and cholesterol during growth in macrophages and in axenic culture. Facilitates the uptake of these lipids by stabilizing protein subunits of the Mce1 and Mce4 multi-subunit transporters, which transport fatty acids and cholesterol, respectively. Required for full virulence in vivo.

Functional vocabulary (eggNOG-mapper, orthology transfer)

Orthologous group2AKY4
Gene Ontology (12) GO:0005575, GO:0005623, GO:0005886, GO:0005887, GO:0016020, GO:0016021, GO:0031224, GO:0031226, GO:0044425, GO:0044459, GO:0044464, GO:0071944

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.716 · relaxed/neutral
Polymorphic sites (≥ 0.1% of strains) 3 synonymous, 6 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Mycobacteriaceae

M. canettii dN/dS (deep-divergence selection) undefined (dS = 0) (low power) · 1 consensus substitution(s)
low power (1 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 80.8% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 1/13 non-Mycobacterium reference genomes (down to Mycobacteriaceae) · mean identity 56.3%
detected in the sister family Mycobacteriaceae (M. abscessus) but not in the broader Corynebacteriales — a Mycobacteriaceae-restricted gene (single-genome rung: interpret with care)

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis)

DeJesus 2017 callNE · non-essential
What the call meansnon-essential
TA sites (Himar1) 10 in the ORF — 0 in the essential state, 0 growth-defect, 10 non-essential, 0 growth-advantage. Saturation 1.000, mean read count 181.7. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 10 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Mutant phenotypes (conditional Tn-seq, MtbTnDB) in-vivo phenotype

Conditionlog2FCqEffect
fitness after prolonged in vitro passage (in vitro passage) -4.550.0048 required
fitness in mouse infection (in vivo) -4.540.011 required
fitness in mouse infection (in vivo) -3.730.029 required
fitness in mouse infection (in vivo) -3.690.025 required
fitness in mouse infection (in vivo) -3.550.0074 required
fitness in mouse infection (in vivo) -3.530.018 required
fitness in mouse infection (in vivo) -3.410.027 required
fitness in mouse infection (in vivo) -3.390.022 required
fitness in mouse infection (in vivo) -3.210.025 required
fitness in mouse infection (in vivo) -3.140.047 required
fitness in mouse infection (in vivo) -3.130.046 required
fitness in mouse infection (in vivo) -3.090.042 required

Conditional fitness of transposon-disruption mutants across 31 significant condition(s) — the table lists the 12 strongest by |log2FC|, not all 31 (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Proteomics (mass spectrometry) detected

MS detectiondetected in 11 of 16 independent MS datasets
Integrated abundance143.0 ppm · rank 1041/3519 (70.4th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox)

Predictionpredicted membrane protein (4 TM helixes)
DeepTMHMM classTM
TM helices (DeepTMHMM)4

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length254 aa
Molecular weight27.4 kDa
Theoretical pI9.15
GRAVY-0.178 (hydrophilic)
Aliphatic index86.2
Aromaticity0.071
Instability index55.8 (unstable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
LUCAPF26307.1 1.3e-683–137 Lipid uptake coordinator A family

3D structure (interactive — Mol*/pdbe-molstar)

No experimental structure is deposited for this gene: showing the AlphaFold DB predicted model (mean pLDDT 71.1, confident), coloured by per-residue confidence (dark blue = very high, orange/red = low — treat low-confidence regions as unreliable, especially termini and loops). Drag to rotate, scroll to zoom.

Genomic context (neighbours & predicted operon)

Upstream (5' on genome)serV (+ strand, 105 bp gap)
Downstream (3' on genome)Rv3725 (+ strand, 913 bp gap)

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton)
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT3826) exponential phase: operon of 4, Rv3723 · Rv3724B · Rv3725 · Rv3726 (coverage 100.59)
stationary phase: operon of 2, Rv3723 · Rv3724B (coverage 24.92) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Additional regulons (curated, outside the TFOE-derived TRN)

crp binding site only -- direction not determined (low confidence · CRP regulon (Kahramanoglou et al. 2014))
ChIP-seq : site de fixation CRP (1 des 191 sites de Kahramanoglou et al. 2014) ; aucun changement d'expression rapporte pour ce gene chez le mutant delta-crp
Caveat: Site de fixation CRP mesure par ChIP-seq (Kahramanoglou et al. 2014), SANS changement d'expression mesure pour ce gene chez le mutant delta-crp : le sens de la regulation n'est PAS determine. Ecrire « site de fixation CRP en amont », jamais « regule par CRP ». L'article ne distingue pas « non differentiellement exprime » de « sous le seuil », donc l'absence de ce gene de la table d'expression n'est pas une preuve de non-regulation.

Curated from primary literature not covered by the ISB signed TRN (Minch 2015 / Rustad 2014): Zur regulon (Maciag et al. 2007, PMID 17098899), SigG regulon (Gaudion et al. 2013, PMID 23871545), LexA/SOS regulon (Smollett et al. 2012, PMID 22528497) — added P16.25 (2026-08-18); CRP regulon (Kahramanoglou et al. 2014, PMID 24957601) — added P16.25b (2026-09-27). Confidence and caveats are per-edge and carried from the source paper — read them before citing a specific gene as "regulated by" its listed TF. An entry reading "binding site only — direction not determined" is not a regulation claim: it records a measured ChIP-seq binding site for which the source reports no expression change, and the absence of such a change is not evidence of absent regulation.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: Rv3722c (hypothetical protein), medium confidence (score 510, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence).

Showing the 15 strongest of this gene's 17 partners at medium confidence (4 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 17 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv3722c hypothetical protein 510 510 ctx neighborhood:507
Rv3724B cut5b Rv3724B, (MTV025.072), len: 187 aa. Probable cut5b,truncated cutinase, similar to C-terminal end of others e.g. Q9XB09|RVD2-RV1758 protein ( 468 468 ctx neighborhood:463
Rv3724A cut5a Rv3724A, (MTV025.072), len: 80 aa. Probable cut5a,truncated cutinase precursor, similar to N-terminal end of others e.g. Q9KK87 serine ester 468 468 ctx neighborhood:463
Rv2219 transmembrane protein 442 55 textmining:434
Rv0547c oxidoreductase 861 50 textmining:860
Rv1013 pks16 polyketide synthase 439 50 textmining:434
Rv3499c mce4A Mce family protein Mce4A 650 47 textmining:648
Rv1226c transmembrane protein 436 47 textmining:433
Rv0587 yrbE2A hypothetical protein 808 44 textmining:808
Rv3445c esxU ESAT-6 like protein EsxU 441 44 textmining:440
Rv3234c tgs3 diacyglycerol O-acyltransferase 435 44 textmining:434
Rv1964 yrbE3A integral membrane protein 403 44 textmining:402
Rv3484 cpsA hypothetical protein 436 42 textmining:436
Rv2308 hypothetical protein 860 41 textmining:860
Rv1414 hypothetical protein 860 41 textmining:860

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: transmembrane protein
  • MTBC0 PGAP product: lipid uptake coordinator LucA
  • Pfam (hmmscan --cut_ga): LUCA PF26307.1 (E=1e-68)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_218240.1)
  • Domains: Pfam-A via hmmscan --cut_ga — LUCA (PF26307.1)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG 2AKY4
  • Curated reference: UniProt O69690 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 71.1)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 17 functional partner(s); context anchor Rv3722c
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_003948|Rv3723|lucA
MGRKVAVLWHASFSIGAGVLYFYFVLPRWPELMGDTGHSLGTGLRIATGALVGLAALPVVFTLLRTRKPELGTPQLALSMRIWSIMAHVLAGALIVGTAISEVWLSLDAAGQWLFGIYGAAAAIAVLGFFGFYLSFVAELPPPPPKPLKPKKPKQRRLRRKKTAKGDEAEPEAAEEAENTELAAQEDEEAVEAPPESIESPGGEPESATREAPAAETATAEEPRGGLRNRRPTGKTSHRRRRTRSGVQVAKVDE